Breen Michael Martin
SEC CIK 1863633 · EDGAR
BoughtSold
Most active insiders at GTBP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Breen Michael Martin made no open-market trades at GTBP in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-15 | 2023-08-11 | GTBP | GT Biopharma, Inc. | Breen Michael Martin | Executive COB, Interim CEO, Dir | A - Grant | $0.29 | +200.0K | 856.2K | +30% | +$58.0K | |
| D | 2023-05-05 | 2023-05-03 | PROP | Prairie Operating Co. | Breen Michael Martin | Dir | P - Purchase | $0.11 | +916.1K | 926.1K | +9,161% | +$100.8K |
| D | 2023-05-05 | 2023-05-03 | PROP | Prairie Operating Co. | Breen Michael Martin | Dir | A - Grant | $0.18 | +218.6K | 1.14M | +24% | +$39.3K |
| 2023-04-11 | 2023-04-11 | GTBP | GT Biopharma, Inc. | Breen Michael Martin | Executive COB, Interim CEO, Dir | P - Purchase | $0.5 | +50.0K | 656.2K | +8% | +$25.0K | |
| D | 2022-07-19 | 2022-07-15 | GTBP | GT Biopharma, Inc. | Breen Michael Martin | Exec. COB, Interim CEO, Dir | A - Grant | $0.00 | +278.1K | 606.2K | +85% | $0 |
| DM | 2021-11-12 | 2021-02-25 | GTBP | GT Biopharma, Inc. | Breen Michael Martin | Dir | C - Cnv Deriv | $3.40 | +50.1K | 318.3K | +19% | +$170.3K |
| D | 2021-11-12 | 2021-02-16 | GTBP | GT Biopharma, Inc. | Breen Michael Martin | Dir | A - Grant | $0.00 | +278.1K | 278.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations